John P. Hamill, SrVP/CFO/Prin Fin & Acct Ofcr at Aprea Therapeutics, holds 43.53K shares in Aprea Therapeutics (Ticker: APRE), holds ― shares in Cellectar Biosciences (Ticker: CLRB), holds 72.80K shares in Windtree Therapeutics (Ticker: WINT).
What is the percentage of profitable transactions made by John P. Hamill?
The percentage of profitable transactions made by John P. Hamill is 20%.
What is the average return per transaction made by John P. Hamill?
The average return per transaction made by John P. Hamill is -41.90%.
What stocks does John P. Hamill hold?
John P. Hamill holds: APRE, CLRB, TRVN, WINT stocks.
What was John P. Hamill’s latest transaction?
John P. Hamill latest transaction was an Uninformative Buy of ―.
What was John P. Hamill's most profitable transaction?
John P. Hamill’s most profitable transaction was an Informative Buy of TRVN stock on June 4, 2019. The return on the trade was 19.80%.
What is John P. Hamill's role in Aprea Therapeutics?
John P. Hamill's role in Aprea Therapeutics is SrVP/CFO/Prin Fin & Acct Ofcr.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.